Tabid, Dan Aiza .
HRN: 20-46-76 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
CEFUROXIME 750MG (VIAL)
09/29/2022
10/06/2022
IVTT
285mg
Q12h
Pcap
Waiting Final Action